NDC 63629-8816

Glatopa

Glatiramer Acetate

Glatopa is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Glatiramer Acetate.

Product ID63629-8816_7392939b-02ff-42c0-9120-2e24a2bf205f
NDC63629-8816
Product TypeHuman Prescription Drug
Proprietary NameGlatopa
Generic NameGlatiramer Acetate
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2018-02-12
Marketing CategoryANDA /
Application NumberANDA206921
Labeler NameBryant Ranch Prepack
Substance NameGLATIRAMER ACETATE
Active Ingredient Strength40 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63629-8816-1

12 BLISTER PACK in 1 CARTON (63629-8816-1) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS
Marketing Start Date2021-09-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Glatopa" or generic name "Glatiramer Acetate"

NDCBrand NameGeneric Name
0781-3234GlatopaGlatiramer Acetate
0781-3250GlatopaGlatiramer Acetate
63629-8815GlatopaGlatiramer Acetate
63629-8816GlatopaGlatiramer Acetate
68546-317CopaxoneGlatiramer Acetate
68546-325CopaxoneGlatiramer Acetate
0378-6960Glatiramer Acetateglatiramer acetate

Trademark Results [Glatopa]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GLATOPA
GLATOPA
86390315 4819540 Live/Registered
Novartis AG
2014-09-10
GLATOPA
GLATOPA
85271930 not registered Dead/Abandoned
Novartis AG
2011-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.